Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
Abstract Background Extremely preterm infants have a high mortality and morbidity. Here, we present a statistical analysis plan for secondary Bayesian analyses of the pragmatic, sufficiently powered multinational, trial—SafeBoosC III—evaluating the benefits and harms of cerebral oximetry monitoring...
Main Authors: | Markus Harboe Olsen, Mathias Lühr Hansen, Theis Lange, Christian Gluud, Lehana Thabane, Gorm Greisen, Janus Christian Jakobsen, the SafeBoosC-III Trial Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07720-3 |
Similar Items
-
Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III
by: Maria Linander Vestager, et al.
Published: (2024-04-01) -
Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-III
by: Marie Isabel Skov Rasmussen, et al.
Published: (2024-10-01) -
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial
by: Maria Linander Vestager, et al.
Published: (2023-10-01) -
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
by: Marie Isabel Rasmussen, et al.
Published: (2023-10-01) -
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
by: Anne M Plomgaard, et al.
Published: (2017-01-01)